Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force.
暂无分享，去创建一个
W. März | M. Banach | J. Zamorano | P. Magni | E. Bruckert | Ž. Reiner | D. Gaita | L. Tokgözoğlu | E. Ros | A. Catapano | L. Masana | A. Zambon | M. Farnier | Jane K. Stock | H. Drexel | M. Averna | M. Vrablik | A. Mello e Silva | M. Vrablík